Jin Medical International... (ZJYL)
NASDAQ: ZJYL
· Real-Time Price · USD
0.62
-0.01 (-1.96%)
At close: Aug 15, 2025, 3:59 PM
0.61
-0.76%
After-hours: Aug 15, 2025, 04:04 PM EDT
Jin Medical International Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | 940.92K | 940.92K | 897.05K | 897.05K | 1.11M | 555.94K | 883.17K | 883.17K | 740.33K | 740.33K | 612.93K | 612.93K | 395.34K | 395.34K | 920.52K | 920.52K |
Depreciation & Amortization | 88.99K | 88.99K | 84.08K | 84.08K | 108.99K | 55.72K | 57.23K | 57.23K | 108.45K | 108.45K | 72.85K | 72.85K | 90.5K | 90.5K | 82.8K | 82.8K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -101.92K | -101.92K | -294.46K | -572.68K | -664.04K | -401.18K | 9.15K | 9.15K | 57.59K | 57.59K | 17.18K | 17.18K | -208.7K | -208.7K | -179.43K | -179.44K |
Other Non-Cash Items | 127.99K | 127.99K | -178.2K | -154.49K | 320.7K | -447.33K | 250.82K | 250.82K | 72.28K | 72.28K | -805.92K | -805.92K | -545.77K | -545.77K | 588.99K | 588.99K |
Deferred Income Tax | n/a | n/a | 23.71K | n/a | 21.04K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.79M | -1.79M | -801.63K | -801.63K | -822.88K | 17.13K | 180.52K | 180.52K | -105.09K | -105.09K | 94.51K | 94.51K | 1.07M | 1.07M | 319.73K | 319.73K |
Operating Cash Flow | -628.65K | -628.65K | 25K | 25K | 362.91K | 181.46K | 1.37M | 1.37M | 815.97K | 815.97K | -25.64K | -25.64K | 1.01M | 1.01M | 1.91M | 1.91M |
Capital Expenditures | -30.64K | -30.64K | -41.84K | -41.84K | -102.92K | -51.46K | -5.51K | -5.51K | -13.02K | -13.02K | -7.06K | -7.06K | -12.55K | -12.55K | -8.89K | -8.89K |
Cash Acquisitions | n/a | n/a | n/a | n/a | 10.04K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -16.14M | n/a | -8.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | 8.81M | n/a | 3.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -2.65M | -2.65M | 5.29M | -2.03M | 4.76M | -276.75K | -3.53M | -3.53M | -27.02K | -27.02K | -13.34K | -13.34K | -753.49K | -753.49K | 241.11K | 241.11K |
Investing Cash Flow | -2.68M | -2.68M | -2.07M | -2.07M | -656.42K | -328.21K | -3.54M | -3.54M | -40.04K | -40.04K | -20.41K | -20.41K | -766.05K | -766.05K | 232.23K | 232.23K |
Debt Repayment | n/a | n/a | n/a | n/a | 2.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.83M | 2.83M | 3M | 3M | -4.35M | -594.63K | 4.05M | 4.05M | 64.16K | 64.16K | -3.23K | -3.23K | -1.2M | -1.2M | -231.83K | -231.83K |
Financial Cash Flow | 2.83M | 2.83M | 3M | 3M | -1.19M | -594.63K | 4.05M | 4.05M | 64.16K | 64.16K | -3.23K | -3.23K | -1.2M | -1.2M | -231.83K | -231.83K |
Net Cash Flow | n/a | n/a | 1.95M | 972.7K | -1.75M | -9.56M | 8.68M | 1.95M | 575.29K | -3.64M | -15.1K | -15.1K | -938.01K | -938.01K | 1.94M | 1.94M |
Free Cash Flow | -659.29K | -659.29K | -16.84K | -16.84K | 259.99K | 129.99K | 1.37M | 1.37M | 802.95K | 802.95K | -32.7K | -32.7K | 997.05K | 997.05K | 1.9M | 1.9M |